Background Postpartum haemorrhage (PPH) is the leading cause of maternal mortality
worldwide. Prophylactic uterotonic agents can prevent PPH, and are routinely …

Objectives: To review the literature to determine the most effective methods for preventing
postpartum hemorrhage (PPH), the single most important cause of maternal death …

Background Postpartum haemorrhage is a major cause of maternal mortality in the
developing world. Although effective methods for prevention and treatment of such …

Background Prostaglandins have mainly been used for postpartum haemorrhage (PPH)
when other measures fail. Misoprostol, a new and inexpensive prostaglandin E1 analogue …

OBJECTIVE: To estimate whether the length of the third stage of labor is correlated with
postpartum hemorrhage. METHODS: In this prospective observational study women …

Postpartum hemorrhage due to uterine atony is the primary direct cause of maternal
mortality globally. Management strategies in developed countries involve crystalloid fluid …

BACKGROUND The copper intrauterine device (IUD) is a highly effective and safe
contraceptive method, also in nulliparous women. However, insertion of an IUD through a …

OBJECTIVE: To review maternal deaths and the dose-related effects of misoprostol on blood
loss and pyrexia in randomized trials of misoprostol use for the prevention or treatment of …

Despite the strong interest of international health agencies, worldwide maternal mortality
has not declined substantially over the past 10 years. Postpartum hemorrhage (PPH) is the …

BACKGROUND Postpartum haemorrhage (PPH) is the leading cause of maternal mortality
worldwide. Prophylactic uterotonic drugs can reduce blood loss and are routinely …